Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Lisata Therapeutics (LSTA) over the last 11 years, with Q3 2025 value amounting to $708000.0.

  • Lisata Therapeutics' Treasury Shares changed 0.0% to $708000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $708000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $708000.0 for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Lisata Therapeutics reported Treasury Shares of $738.0 as of Q3 2025, which was down 0.0% from $738.0 recorded in Q2 2025.
  • Over the past 5 years, Lisata Therapeutics' Treasury Shares peaked at $738.0 during Q1 2023, and registered a low of $738.0 during Q1 2023.
  • Over the past 3 years, Lisata Therapeutics' median Treasury Shares value was $738.0 (recorded in 2023), while the average stood at $738.0.
  • Over the last 5 years, Lisata Therapeutics' Treasury Shares had its largest YoY gain of 0.0% in 2024, and its largest YoY loss of 0.0% in 2024.
  • Over the past 3 years, Lisata Therapeutics' Treasury Shares (Quarter) stood at $708000.0 in 2023, then changed by 0.0% to $708000.0 in 2024, then changed by 0.0% to $708000.0 in 2025.
  • Its last three reported values are $708000.0 in Q3 2025, $708000.0 for Q2 2025, and $708000.0 during Q1 2025.